| Cat. No. |
Product Name |
Information |
| PC-20766 |
ZINC000443438219
SERT inhibitor
|
ZINC000443438219 (Compound 8219) is a highly potent, selective and non-competitive inhibitor of serotonin transporter (SERT) with Ki of 3 nM. |
| PC-20765 |
ZINC000006658090
SERT inhibitor
|
ZINC000006658090 (Compound 8090) is a highly potent, selective and non-competitive inhibitor of serotonin transporter (SERT) with Ki of 14 nM. |
| PC-20070 |
JJC8-091
DAT inhibitor
|
JJC8-091 is a potent, Modafinil-derived dopamine transporter (DAT) ligand / inhibitor with Ki of 16.7 nM, attenuates compulsive-like methamphetamine self-administration in rats. |
| PC-20069 |
JJC8-016
DAT ligand
|
JJC8-016 is a potent, Modafinil-derived dopamine transporter (DAT) ligand with Ki of 116 nM, attenuates compulsive-like methamphetamine self-administration in rats. |
| PC-20068 |
JJC8-088
DAT ligand
|
JJC8-088 is a potent, Modafinil-derived dopamine transporter (DAT) ligand / inhibitor with Ki of 2.53 nM. |
| PC-20035 |
FFN200 dihydrochloride
VMAT2 fluorescent
|
FFN200 dihydrochloride is a vesicular monoamine transporter 2 (VMAT2) substrate, and the first probe to selectively trace monoamine exocytosis in both neuronal cell culture and brain tissue. |
| PC-20034 |
FFN200
Fluorescent false neurotransmitter
|
FFN200 is a vesicular monoamine transporter 2 (VMAT2) substrate, and the first probe to selectively trace monoamine exocytosis in both neuronal cell culture and brain tissue. |
| PC-49734 |
NBI-98782
VMAT2 inhibitor
|
NBI-98782 (RRR-dihydrotetrabenazine, RRR-DHTBZ, (+)-α-HTBZ) is a potent, highly selective VMAT2 inhibitor (Ki=2 nM) and tetrabenazine metabolite. |
| PC-49497 |
SRI-20041
DAT inhibitor
|
SRI-20041 is a small molecule allosteric dopamine transporter ligand. |
| PC-49495 |
SRI-32743
DAT inhibitor
|
SRI-32743 is a novel allosteric modulator of dopamine transporter (DAT), attenuates HIV-1 Tat protein-induced inhibition of the dopamine transporter. |
| PC-47109 |
GZ-794A
VMAT2 inhibitor
|
GZ-794A is a potent, selective inhibitor of vesicular monoamine transporter-2 (VMAT2) with Ki of 30 nM, inhibits methamphetamine-evoked endogenous dopamine release with IC50 of 0.4 uM. |
| PC-47108 |
GZ-793A
VMAT2 inhibitor
|
GZ-793A is a potent, selective inhibitor of vesicular monoamine transporter-2 (VMAT2) with Ki of 30 nM, inhibits methamphetamine-evoked endogenous dopamine release with IC50 of 10.6 uM. |
